Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature

References

• Poller DN, van Wyk Q, Jeffrey MJ. The importance of skip lesions in temporal arteritis. J Clin Pathol. 2000;53:137–139.
   PubMed Web of Science ®Google Scholar
• Weyand C, Liao J, Goronzy J. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol. 2012;32(3):259–265. doi:10.1097/WNO.0b013e318268aa9b.
   PubMed Web of Science ®Google Scholar
• Nagel MA, Gilden D. Developments in varicella zoster virus vasculopathy. Curr Neurol Neurosci Rep. 2016; 16(12):doi: 10.1007/s11910-015-0614-5.
   PubMed Web of Science ®Google Scholar
• Ciccia F, Rizzo A, Ferrante A, et al. New insights into the pathogenesis of giant cell arteritis. Autoimmun Rev. 2017;16:675–683. doi:10.1016/j.autrev.2017.05.004.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Kinjo M, Hokamura K, Tanaka K. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke. 1986;17:1024–1028.
   PubMed Web of Science ®Google Scholar
• Kosa SC, Younge BR, Kumar N. Headaches due to giant cell arteritis following herpes zoster ophthalmicus in an elderly patient. Cephalalgia. 2009;30(2):239–241. doi:10.1111/j.1468-2982.2009.01880.x.
   Web of Science ®Google Scholar
• Mathias M, Nagel MA, Khmeleva N, et al. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci. 2013;325(1–2):180–182. doi:10.1016/j.jns.2012.12.021.
   PubMed Web of Science ®Google Scholar
• Teodoro T, Nagel MA, Geraldes R, et al. Gilden D.Biopsy-negative, varicella zoster virus (VZV)-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one. J Neurol Sci. 2014 Aug 15;343(1–2):195–197. doi:10.1016/j.jns.2014.05.035.
   PubMed Web of Science ®Google Scholar
• Gilden D. Association of varicella zoster virus with giant cell arteritis. Monoclon Antib Immunodiagn Immunother. 2014;33(3):168–172. doi:10.1089/mab.2014.0020.
   PubMedGoogle Scholar
• Hu D, Mohanta SK, Yin C, et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors. Immunity. 2015;42:1100–1115. doi:10.1016/j.immuni.2015.05.015.
   PubMed Web of Science ®Google Scholar
• Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol. 2015;72(11):1281–1287. doi:10.1001/jamaneurol.2015.2101.
   PubMed Web of Science ®Google Scholar
• Nordborg C, Nordborg E, Petursdottir V, et al. Search for varicella zoster virus in giant cell arteritis. Ann Neurol. 1998;44(3):413–414. doi:10.1002/ana.410440323.
   PubMed Web of Science ®Google Scholar
• Mitchell BM, Font RL. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest Ophthalmol Vis Sci. 2001;42:2572–2577.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatol. 2002;41:445–449. doi:10.1093/rheumatology/41.4.445.
   PubMed Web of Science ®Google Scholar
• Kennedy PGE, Grinfeld E, Esiri MM. Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J Neurol Sci. 2003;215:27–29.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pla A, Bosch-Gil JA, Echevarria-Mayo JE, et al. No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. J Clin Virol. 2004;31(1):11–15. doi:10.1016/j.jcv.2004.05.003.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lafuente R, Fernandez-Gutierrez B, Jover JA, et al. Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis. 2005 May;64(5):780–782. doi:10.1136/ard.2004.025320.
   PubMed Web of Science ®Google Scholar
• Cooper RJ, D‘Arcy S, Kirby M, et al. Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens. J Med Virol. 2008;80(3):501–505. doi:10.1002/jmv.21092.
   PubMed Web of Science ®Google Scholar
• Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80(22):2017–2021. doi:10.1212/WNL.0b013e318294b477.
   PubMed Web of Science ®Google Scholar
• Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84(19):1948–1955. doi:10.1212/WNL.0000000000001409.
   PubMed Web of Science ®Google Scholar
• Gilden D, White T, Boyer PJ, et al. Varicella zoster virus infection in granulomatous arteritis of the aorta. J Infect Dis. 2016;213(12):1866–1871. doi:10.1093/infdis/jiw101.
   PubMed Web of Science ®Google Scholar
• Gilden D, White T, Khmeleva N, Boyer P, Nagel M. VZV in biopsy-positive and negative giant cell arteritis: analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm. 2016;3:e216. doi:10.12/NXI.0000000000000216.
   PubMed Web of Science ®Google Scholar
• Gilden D, White T, Khmeleva N, Katz BJ, Nagel MA. Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries. J Neurol Sci. 2016;364:141–143. doi:10.1016/j.jns.2016.03.020.
   PubMed Web of Science ®Google Scholar
• Muratore F, Croci S, Tamagnini I, et al. No detection of varicella-zoster virus in temporal arteries of patients with giant cell arteritis. Semin Arthritis Rheum. 2017;47(2):235–240. doi:10.1016/j.semarthrit.2017.02.005.
   PubMed Web of Science ®Google Scholar
• Procop GW, Eng C, Clifford A, et al. Varicella zoster virus and large vessel vasculitis, the absence of an association. Pathog Immun. 2017;2(2):228–238.doi:10.20411/pai.v2i2.196.
   PubMedGoogle Scholar
• Buckingham EM, Foley MA, Grose C, et al. Identification of herpes zoster-associated temporal arteritis among cases of giant cell arteritis. Am J Ophthalmol. 2018;187:51–60. doi:10.1016/j.ajo.2017.12.017.
   PubMed Web of Science ®Google Scholar
• Salazar R, Russman AN, Nagel MA, et al. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol. 2011 Apr;68(4):517–520. doi:10.1001/archneurol.2011.64.
   PubMedGoogle Scholar
• Nagel M, Khemeleva N, Boyer P, Choe A, Bert R, Gilden D. Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci. 2013;335:228–230. doi:10.1016/j.jns.2013.09.034.
   PubMed Web of Science ®Google Scholar
• Martin JR, Mitchell WJ, Henken DB. Neurotropic herpesviruses, neural mechanisms and arteritis. Brain Pathol. 1990;1:6–10.
   PubMed Web of Science ®Google Scholar
• Rondaan C, van der Geest KSM, Eelsing E, et al. Decreased immunity to varicella zoster virus in giant cell arteritis. Front Immunol. 2017;8:1377. doi:10.3389/fimmu.2017.01377.
   PubMed Web of Science ®Google Scholar
• Lotan I, Steiner I. zoster vaccination. J Neurol Sci. 2017;375:158–159. doi:10.1016/j.jns.2017.01.053.
   PubMed Web of Science ®Google Scholar
• Ing EB, Ing R, Liu X, et al. Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study. Clin Ophthalmol. 2018;12:113–118. doi:10.2147/OPTH.S151893.
   PubMed Web of Science ®Google Scholar
• Goon P, Wright M, Fink C. Ophthalmic zoster sine herpete. J R Soc Med. 2000;93(4):191–192. doi:10.1177/014107680009300409.
   PubMed Web of Science ®Google Scholar
• Huward J, Feero WG, Watkins SC, Hoffman EP, Rosenblatt DJ, GLorioso JC. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J Virol. 1996;70:8117–8123.
   PubMed Web of Science ®Google Scholar
• van Deutekom JC, Floyd SS, Booth DK, et al. Implications of maturation for viral gene delivery to skeletal muscle. Neuromuscul Disord. 1996;8(3–4):135–148. doi:10.1016/S0960-8966(98)00019-4.
   Web of Science ®Google Scholar
• Jones D, Blackmon A, Neff CP, et al. Varicella-zoster virus downregulates programmed death ligand 1 and major histocompatibility complex class i in human brain vascular adventitial fibroblasts, perineurial cells, and lung fibroblasts. J Virol. 2016;90(23):10527–10534. doi:10.1128/JVI.01546-16.
   PubMed Web of Science ®Google Scholar
• Liao YJ, Kedar S. Should antiviral/anti-varicella zoster virus treatment be used in patients with giant cell arteritis? J Neuroophthalmol. 2019;39(1):134–141. doi:10.1097/WNO.0000000000000664.
   PubMed Web of Science ®Google Scholar